Medication Guide - 2/4/2022

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More Drug Name Active Ingredient Form;Route Appl. No. Company Date Copiktra Duvelisib CAPSULE;ORAL 211155 SECURA 02/02/2022 Juxtapid Lomitapide Mesylate CAPSULE;ORAL 203858 AMRYT 02/01/2022 Citalopram Citalopram Hydrobromide CAPSULE; ORAL 215428 ALMATICA 01/31/2022 Lynparza Olaparib TABLET;ORAL 208558 ASTRAZENECA 01/31/2022 Sutab Magnesium Sulfate; Potassium Chloride; Sodium Sulfate TABLET;ORAL 213135 BRAINTREE LABS 01/28/2022 Tafinlar Dabrafenib Mesylate CAPSULE;ORAL 202806 NOVARTIS 01/28/2022 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA